The Michael Mason Prize: Development and feasibility testing of a complex intervention to improve adherence to fracture prevention medicine
(2025)
Journal Article
Bullock, L., Tyler, N., Fleming, J., Clark, E. M., Thomas, S., Gidlow, C., Iglesias-Urrutia, C. P., Horne, R., Bentley, I., Hawarden, A., Peel, N., Gregson, C. L., Ralston, S. H., Protheroe, J., Lefroy, J., Ryan, S., O’Neill, T. W., Mallen, C., Jinks, C., & Paskins, Z. (2025). The Michael Mason Prize: Development and feasibility testing of a complex intervention to improve adherence to fracture prevention medicine. Rheumatology, https://doi.org/10.1093/rheumatology/keaf413
Objectives Only 12% of people recommended fracture prevention medicines remain on treatment 1 year post fracture. The improving uptake of Fracture Prevention treatments (iFraP) intervention aims to improve shared decision-making (SDM) about, and upta... Read More about The Michael Mason Prize: Development and feasibility testing of a complex intervention to improve adherence to fracture prevention medicine.